Interferon alpha bioactivity critically depends on Scavenger receptor class B type I function

References

• Calvo D, Vega MA. Identification, primary structure, and distribution of CLA-1, a novel member of the CD36/LIMPII gene family. J Biol Chem 1993; 268:18929-35; PMID:7689561
   PubMed Web of Science ®Google Scholar
• Acton SL, Scherer PE, Lodish HF, Krieger M. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J Biol Chem 1994; 269:21003-9; PMID:7520436
   PubMed Web of Science ®Google Scholar
• Williams DL, de La Llera-Moya M, Thuahnai ST, Lund-Katz S, Connelly MA, Azhar S, Anantharamaiah GM, Phillips MC. Binding and cross-linking studies show that scavenger receptor BI interacts with multiple sites in apolipoprotein A-I and identify the class A amphipathic alpha-helix as a recognition motif. J Biol Chem 2000; 275:18897-904; PMID:10858447; http://dx.doi.org/10.1074/jbc.M002411200
   PubMed Web of Science ®Google Scholar
• Calvo D, Gomez-Coronado D, Lasuncion MA, Vega MA. CLA-1 is an 85-kD plasma membrane glycoprotein that acts as a high-affinity receptor for both native (HDL, LDL, and VLDL) and modified (OxLDL and AcLDL) lipoproteins. Arterioscler, Thromb Vasc Biol 1997; 17:2341-9; PMID:9409200; http://dx.doi.org/10.1161/01.ATV.17.11.2341
   PubMed Web of Science ®Google Scholar
• Fioravanti J, Medina-Echeverz J, Berraondo P. Scavenger receptor class B, type I: a promising immunotherapy target. Immunotherapy 2011; 3:395-406; PMID:21395381; http://dx.doi.org/10.2217/imt.10.104
   PubMed Web of Science ®Google Scholar
• Cai L, Wang Z, Meyer JM, Ji A, van der Westhuyzen DR. Macrophage SR-BI regulates LPS-induced pro-inflammatory signaling in mice and isolated macrophages. J Lipid Res 2012; 53:1472-81; PMID:22589557; http://dx.doi.org/10.1194/jlr.M023234
   PubMed Web of Science ®Google Scholar
• Cai L, Ji A, de Beer FC, Tannock LR, van der Westhuyzen DR. SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance. J Clin Investigat 2008; 118:364-75; PMID:18064300; http://dx.doi.org/10.1172/JCI31539
   PubMed Web of Science ®Google Scholar
• Gowdy KM, Madenspacher JH, Azzam KM, Gabor KA, Janardhan KS, Aloor JJ, Fessler MB. Key role for scavenger receptor B-I in the integrative physiology of host defense during bacterial pneumonia. Mucosal Immunol 2015; 8:559-71; PMID:25336169; http://dx.doi.org/10.1038/mi.2014.88
   Web of Science ®Google Scholar
• Feng H, Guo L, Wang D, Gao H, Hou G, Zheng Z, Ai J, Foreman O, Daugherty A, Li XA. Deficiency of scavenger receptor BI leads to impaired lymphocyte homeostasis and autoimmune disorders in mice. Arterioscler Thromb Vasc Biol 2011; 31:2543-51; PMID:21836069; http://dx.doi.org/10.1161/ATVBAHA.111.234716
   PubMed Web of Science ®Google Scholar
• Gomaraschi M, Calabresi L, Rossoni G, Iametti S, Franceschini G, Stonik JA, Remaley AT. Anti-inflammatory and cardioprotective activities of synthetic high-density lipoprotein containing apolipoprotein A-I mimetic peptides. J Pharmacol Exp Therap 2008; 324:776-83; PMID:18042829; http://dx.doi.org/10.1124/jpet.107.129411
   PubMed Web of Science ®Google Scholar
• Leelahavanichkul A, Bocharov AV, Kurlander R, Baranova IN, Vishnyakova TG, Souza AC, Hu X, Doi K, Vaisman B, Amar M et al. Class B scavenger receptor types I and II and CD36 targeting improves sepsis survival and acute outcomes in mice. J Immunol 2012; 188:2749-58; PMID:22327076; http://dx.doi.org/10.4049/jimmunol.1003445
   PubMed Web of Science ®Google Scholar
• Baranova IN, Vishnyakova TG, Bocharov AV, Kurlander R, Chen Z, Kimelman ML, Remaley AT, Csako G, Thomas F, Eggerman TL et al. Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogen-activated protein kinases. J Biol Chem 2005; 280:8031-40; PMID:15576377; http://dx.doi.org/10.1074/jbc.M405009200
   PubMed Web of Science ®Google Scholar
• Nobecourt E, Davies MJ, Brown BE, Curtiss LK, Bonnet DJ, Charlton F, Januszewski AS, Jenkins AJ, Barter PJ, Rye KA. The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase. Diabetologia 2007; 50:643-53; PMID:17216278; http://dx.doi.org/10.1007/s00125-006-0574-z
   PubMed Web of Science ®Google Scholar
• Shao B, Cavigiolio G, Brot N, Oda MN, Heinecke JW. Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I. Proc Natl Acad Sci U S A 2008; 105:12224-9; PMID:18719109; http://dx.doi.org/10.1073/pnas.0802025105
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010; 140:805-20; PMID:20303872; http://dx.doi.org/10.1016/j.cell.2010.01.022
   PubMed Web of Science ®Google Scholar
• Hervas-Stubbs S, Perez-Gracia JL, Rouzaut A, Sanmamed MF, Le Bon A, Melero I. Direct effects of type I interferons on cells of the immune system. Clin Cancer Res: Off J Am Assoc Cancer Res 2011; 17:2619-27; PMID:21372217; http://dx.doi.org/10.1158/1078-0432.CCR-10-1114
   PubMed Web of Science ®Google Scholar
• Sozzani S, Bosisio D, Scarsi M, Tincani A. Type I interferons in systemic autoimmunity. Autoimmunity 2010; 43:196-203; PMID:20298124; http://dx.doi.org/10.3109/08916930903510872
   PubMed Web of Science ®Google Scholar
• Pestka S. The interferons: 50 years after their discovery, there is much more to learn. J Biol Chem 2007; 282:20047-51; PMID:17502369; http://dx.doi.org/10.1074/jbc.R700004200
   PubMed Web of Science ®Google Scholar
• Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O, Oudard S, Negrier S, Szczylik C, Kim ST et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. New Engl J Med 2007; 356:115-24; PMID:17215529; http://dx.doi.org/10.1056/NEJMoa065044
   PubMed Web of Science ®Google Scholar
• Scheel TK, Rice CM. Understanding the hepatitis C virus life cycle paves the way for highly effective therapies. Nat Med 2013; 19:837-49; PMID:23836234; http://dx.doi.org/10.1038/nm.3248
   PubMed Web of Science ®Google Scholar
• Escobar-Zarate D, Liu YP, Suksanpaisan L, Russell SJ, Peng KW. Overcoming cancer cell resistance to VSV oncolysis with JAK1/2 inhibitors. Cancer Gene Ther 2013; 20:582-9; PMID:24030211; http://dx.doi.org/10.1038/cgt.2013.55
   PubMed Web of Science ®Google Scholar
• Nguyen TL, Abdelbary H, Arguello M, Breitbach C, Leveille S, Diallo JS, Yasmeen A, Bismar TA, Kirn D, Falls T et al. Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis. Proc Natl Acad Sci U S A 2008; 105:14981-6; PMID:18815361; http://dx.doi.org/10.1073/pnas.0803988105
   PubMed Web of Science ®Google Scholar
• Vigil A, Park MS, Martinez O, Chua MA, Xiao S, Cros JF, Martinez-Sobrido L, Woo SL, Garcia-Sastre A. Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus. Cancer Res 2007; 67:8285-92; PMID:17804743; http://dx.doi.org/10.1158/0008-5472.CAN-07-1025
   PubMed Web of Science ®Google Scholar
• Bocharov AV, Baranova IN, Vishnyakova TG, Remaley AT, Csako G, Thomas F, Patterson AP, Eggerman TL. Targeting of scavenger receptor class B type I by synthetic amphipathic alpha-helical-containing peptides blocks lipopolysaccharide (LPS) uptake and LPS-induced pro-inflammatory cytokine responses in THP-1 monocyte cells. J Biol Chem 2004; 279:36072-82; PMID:15199068; http://dx.doi.org/10.1074/jbc.M314264200
   PubMed Web of Science ®Google Scholar
• Fernandez-Lizarbe S, Montesinos J, Guerri C. Ethanol induces TLR4/TLR2 association, triggering an inflammatory response in microglial cells. J Neurochem 2013; 126:261-73; PMID:23600947; http://dx.doi.org/10.1111/jnc.12276
   PubMed Web of Science ®Google Scholar
• Wang YC, Zhou Y, Fang H, Lin S, Wang PF, Xiong RP, Chen J, Xiong XY, Lv FL, Liang QL et al. Toll-like receptor 2/4 heterodimer mediates inflammatory injury in intracerebral hemorrhage. Ann Neurol 2014; 75:876-89; PMID:24752976; http://dx.doi.org/10.1002/ana.24159
   PubMed Web of Science ®Google Scholar
• Barton GM, Medzhitov R. Toll-like receptor signaling pathways. Science 2003; 300:1524-5; PMID:12791976; http://dx.doi.org/10.1126/science.1085536
   PubMed Web of Science ®Google Scholar
• Nieland TJ, Penman M, Dori L, Krieger M, Kirchhausen T. Discovery of chemical inhibitors of the selective transfer of lipids mediated by the HDL receptor SR-BI. Proc Natl Acad Sci U S A 2002; 99:15422-7; PMID:12438696; http://dx.doi.org/10.1073/pnas.222421399
   PubMed Web of Science ®Google Scholar
• Masson D, Koseki M, Ishibashi M, Larson CJ, Miller SG, King BD, Tall AR. Increased HDL cholesterol and apoA-I in humans and mice treated with a novel SR-BI inhibitor. Arterioscler Thromb Vasc Biol 2009; 29:2054-60; PMID:19815817; http://dx.doi.org/10.1161/ATVBAHA.109.191320
   PubMed Web of Science ®Google Scholar
• Nieland TJ, Chroni A, Fitzgerald ML, Maliga Z, Zannis VI, Kirchhausen T, Krieger M. Cross-inhibition of SR-BI- and ABCA1-mediated cholesterol transport by the small molecules BLT-4 and glyburide. J Lipid Res 2004; 45:1256-65; PMID:15102890; http://dx.doi.org/10.1194/jlr.M300358-JLR200
   PubMed Web of Science ®Google Scholar
• Zoon KC, Arnheiter H, Zur Nedden D, Fitzgerald DJ, Willingham MC. Human interferon alpha enters cells by receptor-mediated endocytosis. Virology 1983; 130:195-203; PMID:6314645; http://dx.doi.org/10.1016/0042-6822(83)90127-7
   PubMed Web of Science ®Google Scholar
• Kumar KG, Barriere H, Carbone CJ, Liu J, Swaminathan G, Xu P, Li Y, Baker DP, Peng J, Lukacs GL et al. Site-specific ubiquitination expose s a linear motif to promote interferon-alpha receptor endocytosis. J Cell Biol 2007; 179:935-50; PMID:18056411; http://dx.doi.org/10.1083/jcb.200706034
   PubMed Web of Science ®Google Scholar
• Marchetti M, Monier MN, Fradagrada A, Mitchell K, Baychelier F, Eid P, Johannes L, Lamaze C. Stat-mediated signaling induced by type I and type II interferons (IFNs) is differentially controlled through lipid microdomain association and clathrin-dependent endocytosis of IFN receptors. Mol Biol Cell 2006; 17:2896-909; PMID:16624862; http://dx.doi.org/10.1091/mbc.E06-01-0076
   PubMed Web of Science ®Google Scholar
• Nestle FO, Di Meglio P, Qin JZ, Nickoloff BJ. Skin immune sentinels in health and disease. Nat Rev Immunol 2009; 9:679-91; PMID:19763149
   PubMed Web of Science ®Google Scholar
• Guo L, Song Z, Li M, Wu Q, Wang D, Feng H, Bernard P, Daugherty A, Huang B, Li XA. Scavenger receptor BI protects against septic death through its role in modulating inflammatory response. J Biol Chem 2009; 284:19826-34; PMID:19491399; http://dx.doi.org/10.1074/jbc.M109.020933
   PubMed Web of Science ®Google Scholar
• Zhu P, Liu X, Treml LS, Cancro MP, Freedman BD. Mechanism and regulatory function of CpG signaling via scavenger receptor B1 in primary B cells. J Biol Chem 2009; 284:22878-87; PMID:19542230; http://dx.doi.org/10.1074/jbc.M109.018580
   PubMed Web of Science ®Google Scholar
• Anantharamaiah GM, Jones JL, Brouillette CG, Schmidt CF, Chung BH, Hughes TA, Bhown AS, Segrest JP. Studies of synthetic peptide analogs of the amphipathic helix. Structure of complexes with dimyristoyl phosphatidylcholine. J Biol Chem 1985; 260:10248-55; PMID:4019510
   PubMed Web of Science ®Google Scholar
• Barbalat R, Lau L, Locksley RM, Barton GM. Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands. Nat Immunol 2009; 10:1200-7; PMID:19801985; http://dx.doi.org/10.1038/ni.1792
   PubMed Web of Science ®Google Scholar
• Brandt KJ, Fickentscher C, Kruithof EK, de Moerloose P. TLR2 ligands induce NF-kappaB activation from endosomal compartments of human monocytes. PloS One 2013; 8:e80743; PMID:24349012; http://dx.doi.org/10.1371/journal.pone.0080743
   PubMedGoogle Scholar
• Zhao LJ, Wang W, Wang WB, Ren H, Qi ZT. Involvement of ERK pathway in interferon alpha-mediated antiviral activity against hepatitis C virus. Cytokine 2015; 72:17-24; PMID:25544181; http://dx.doi.org/10.1016/j.cyto.2014.11.031
   PubMed Web of Science ®Google Scholar
• Bieniasz PD. Intrinsic immunity: a front-line defense against viral attack. Nat Immunol 2004; 5:1109-15; PMID:15496950; http://dx.doi.org/10.1038/ni1125
   PubMed Web of Science ®Google Scholar
• Nieland TJ, Ehrlich M, Krieger M, Kirchhausen T. Endocytosis is not required for the selective lipid uptake mediated by murine SR-BI. Biochimica et Biophysica Acta 2005; 1734:44-51; PMID:15866482; http://dx.doi.org/10.1016/j.bbalip.2005.02.007
   PubMed Web of Science ®Google Scholar
• Liu B, Krieger M. Highly purified scavenger receptor class B, type I reconstituted into phosphatidylcholine/cholesterol liposomes mediates high affinity high density lipoprotein binding and selective lipid uptake. J Biol Chem 2002; 277:34125-35; PMID:12110672; http://dx.doi.org/10.1074/jbc.M204265200
   PubMed Web of Science ®Google Scholar
• Faloon PW, Dockendorff C, Youngsaye W, Yu M, Nag PP, Lewis TA, Bennion M, Paterson C, Lam G, Dandapani S et al. A Small Molecule Inhibitor of Scavenger Receptor BI-mediated Lipid Uptake—Probe 1. 2011 Dec 15 [Updated 2014 Sep 18]. In: Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010; PMID:23658945
   Google Scholar
• Eckhardt ER, Cai L, Shetty S, Zhao Z, Szanto A, Webb NR, Van der Westhuyzen DR. High density lipoprotein endocytosis by scavenger receptor SR-BII is clathrin-dependent and requires a carboxyl-terminal dileucine motif. J Biol Chem 2006; 281:4348-53; PMID:16368683; http://dx.doi.org/10.1074/jbc.M513154200
   PubMed Web of Science ®Google Scholar
• Eckhardt ER, Cai L, Sun B, Webb NR, van der Westhuyzen DR. High density lipoprotein uptake by scavenger receptor SR-BII. J Biol Chem 2004; 279:14372-81; PMID:14726519; http://dx.doi.org/10.1074/jbc.M313793200
   PubMed Web of Science ®Google Scholar
• Thilakawardhana S, Everett DM, Murdock PR, Dingwall C, Owen JS. Quantification of apolipoprotein E receptors in human brain-derived cell lines by real-time polymerase chain reaction. Neurobiol Aging 2005; 26:813-23; PMID:15718039; http://dx.doi.org/10.1016/j.neurobiolaging.2004.08.004
   PubMed Web of Science ®Google Scholar
• Azhar S, Reaven E. Scavenger receptor class BI and selective cholesteryl ester uptake: partners in the regulation of steroidogenesis. Mol Cell Endocrinol 2002; 195:1-26; PMID:12354669; http://dx.doi.org/10.1016/S0303-7207(02)00222-8
   PubMed Web of Science ®Google Scholar
• Uze G, Schreiber G, Piehler J, Pellegrini S. The receptor of the type I interferon family. Curr Topics Microbiol Immunol 2007; 316:71-95; PMID:17969444
   PubMed Web of Science ®Google Scholar
• Crouse J, Kalinke U, Oxenius A. Regulation of antiviral T cell responses by type I interferons. Nat Rev Immunol 2015; 15:231-42; PMID:25790790; http://dx.doi.org/10.1038/nri3806
   PubMed Web of Science ®Google Scholar
• Melero I, Quetglas JI, Reboredo M, Dubrot J, Rodriguez-Madoz JR, Mancheno U, Casales E, Riezu-Boj JI, Ruiz-Guillen M, Ochoa MC et al. Strict requirement for vector-induced type I interferon in efficacious antitumor responses to virally encoded IL12. Cancer Res 2015; 75:497-507; PMID:25527611; http://dx.doi.org/10.1158/0008-5472.CAN-13-3356
   PubMed Web of Science ®Google Scholar
• Quetglas JI, Fioravanti J, Ardaiz N, Medina-Echeverz J, Baraibar I, Prieto J, Smerdou C, Berraondo P. A Semliki forest virus vector engineered to express IFNalpha induces efficient elimination of established tumors. Gene Ther 2012; 19:271-8; PMID:21734727; http://dx.doi.org/10.1038/gt.2011.99
   PubMed Web of Science ®Google Scholar